Novo Nordisk signals beyond the news: 56+ signals from 6 sources
The latest Novo Nordisk signal on this page is from Sep 29, 2026 (Patents): "NOVO NORDISK A/S's patent output is steady: 30 grants in the past year, 2 in the past 30 days." The busiest sources: Glassdoor (15+), LinkedIn (15+) and Website changes (15+).
PublicBusiness Consulting and Services10,000+ employeesnovonordisk.comLinkedIn
- Signals
- 56+
- Sources
- 6
- Last 90 days
- 40
- Latest
- Sep 29, 2026
Other signals · latest 10
Latest Novo Nordisk signals by source
56+ signals for Novo Nordisk across 6 sources.
Patents · Patent pace
NOVO NORDISK A/S's patent output is steady: 30 grants in the past year, 2 in the past 30 days.
Over the past year NOVO NORDISK A/S received 30 US patent grants; the recent pace (6 in 90 days) is steady versus its trailing baseline.
- Grants, 12 months
- 30
- Grants, 90 days
- 6
- Grants, 30 days
- 2
- USPTO assignee
- Novo Nordisk A/S
Reddit · Layoffs
Novo Nordisk has reportedly cut 4,000 jobs more than was initially announced, prompting negative reactions and speculation that the cuts were in R&D.
Post: "Novo has cut 4,000 jobs more than first announced"
- Subreddit
- r/biotech
- Upvotes
- 217
- Comments
- 36
- Sentiment
- Negative
Patents · Patent grant
Novo Nordisk was granted a patent for dual-drug pharmaceutical formulations.
In September 2026 Novo Nordisk patented liquid formulations for co-administering semaglutide and cagrilintide through a dual-chamber device for diabetes and obesity treatment.
- Patent title
- Pharmaceutical formulations
- Grant date
- Sep 22, 2026
- Inventors
- Tommy Sander, Christian Poulsen, Rosa Rebecca Erritzoee Hansen
Reddit · Customer feedback
Novo Nordisk's drug Semaglutide has generated a cumulative, inflation-adjusted revenue of $135 billion, showing strong performance among blockbuster drugs in a comparative chart.
Post: "Cumulative Revenue of Blockbusters"
- Subreddit
- r/biotech
- Upvotes
- 230
- Comments
- 24
- Sentiment
- Positive
Glassdoor · Lack of mentorship
Senior leadership lacks technical skill and loyalty is prioritized over capability
An associate director mentions that senior leadership roles are not open to outsiders and are often filled by loyalty rather than technical or leadership capability, lacking a technology roadmap.
- Overall rating
- 4.0 of 5
- CEO approval
- 78%
- Reviews read
- 10
- Review window
- Aug 31, 2026 to Sep 9, 2026
Glassdoor · Compensation dissatisfaction
Employees report low pay and mediocre peers affecting learning
A computational biologist states that pay is low and peers are mediocre with not much to learn from. A Lean Partner also mentions difficulty in receiving raises or recognition.
- Overall rating
- 4.0 of 5
- CEO approval
- 78%
- Reviews read
- 10
- Review window
- Aug 31, 2026 to Sep 9, 2026
Podcasts · Executive opinion
Hims House discusses Novo Nordisk: executive opinion
"They've gone much more quiet on the legal side. And I just have been much fewer developments that I've at least followed on the lawsuits that they filed last year. And they've gone much more into the sort of the partnership channel of let us work with telehealth to get our branded product out..."
- Podcast
- Hims House
- Episode
- Bijan Salehizadeh - Eli Lilly's War on Compounded GLP-1s, Peptides, Retatrutide, and Hims vs Ro
- Speaker
- Bijan Salehizadeh
- Speaker role
- Third party
Website changes · Technical update
Novo Nordisk reported adjusted operating profit of DKK 33,389 million for Q2 2026 and raised its full-year outlook.
Added news item: “Novo Nordisk reports adjusted operating profit of DKK 33,389 million for Q2 2026 and raises full-year outlook.”
- Page
- /
LinkedIn
Novo Nordisk partners with AWS to accelerate drug discovery using AI.
We are entering into a new strategic partnership with Amazon Web Services (AWS) to accelerate drug discovery through AI. The partnership includes a co-innovation hub in London, where AWS experts will work alongside our scientists to accelerate drug discovery and development. Learn more in the press release here...
- Likes
- 1,925
- Comments
- 23
- Tags
- Artificial Intelligence, Partnership, Product Development, Research & Development
- Initiatives
- accelerate drug discovery through AI
Podcasts · Industry prediction
Out of the Lab: Operationalizing Cell and Gene Therapy discusses Novo Nordisk: industry prediction
"And we see now with Nova Holdings acquiring Catalan, that is a major event... it does exemplify the fact that you know, Novo Holdings and Novo Nordisk now have got in-house critical assets."
- Podcast
- Out of the Lab: Operationalizing Cell and Gene Therapy
- Episode
- The Outsourcing Trap: Why Pharma Needs to Reclaim Manufacturing | Hedley Rees
- Speaker
- Hedley Rees
- Speaker role
- Third party
Showing 10 of 56+ signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Novo Nordisk with the Signal API
One POST /v1/companies/enrich call with novonordisk.com returns Novo Nordisk signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{
"domain": "novonordisk.com",
"signal_types": ["reddit-company","podcast-company","glassdoor-company",
"product-reviews","linkedin-post-company","twitter-company-posts",
"youtube-company","website-intelligence","patents-company",
"federal-contract-award","conference-speaker","hackernews",
"producthunt-launch","seo-traffic"],
"limit": 20
}'Same industry
Other signals at related companies
Questions about Novo Nordisk other signals
What signals does Autobound track for Novo Nordisk besides news and filings?
What are people saying about Novo Nordisk online?
What do employees say about working at Novo Nordisk?
Has Novo Nordisk been granted patents recently?
Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.
Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.
Data as of .